Home › NCT04296071

Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)

Who can join

12 Months · All sexes

Inclusion Criteria:

* Are \< 12months of age
* Scheduled for cardiac surgical needing CPB
* Preoperative SpO2 \> 90%

Exclusion Criteria:

* Lack of parental (or legal guardian's) consent
* Preoperative SpO2 \< 90%
* Preoperative oxygen therapy

About the study

Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.

What is being tested

• Research study (other)

Sponsor: Sophia Koutsogiannaki · Participants: 56 · Started: Oct 14, 2022

Contact the study team

• Sophia Koutsogiannaki, PhD · Phone: 617-919-4725
• Koichi Yuki, MD · Phone: 617-355-6225

Official record on ClinicalTrials.gov — NCT04296071

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.